Midterm 2 Flashcards

1
Q

Verapamil / Diltiazem

A

L-type (vg) Ca2+ channel blockers
Class 4 anti-arrhythmics
tx of supraventricular arrhythmias
↓ Ca2+ entry in SA + AV nodes = ↓ conduction, hr, contractility
pro-arrhythmic action if shortened action in ventricles

anti-anginal drug - ↓ cardiac work
reduce contractility, hr, + afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nifedipine

A

Dihydropyridine
L-type Ca2+ channel blocker
tx of hypertension angina - ↓ cardiac work
reduce contractility, hr, + afterload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Thapsigargin

A

blocks SERCA pump (pumps Ca2+ into SR)
experimentally raises cytoplasmic Ca2+ levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ryanodine

A

agonist of RyR
activates receptor at nanomolar [] but closes receptor at micromolar []

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Caffeine (methylxanthine)

A

sensitizes RyR
causes Ca2+ release from SR at physiological [Ca2+]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dantrolene

A

blocks RyR
used to treat malignant hyperthermia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Isoprenaline

A

B1 agonist = sympathetic stimulation of heart
Gs → AC → ↑cAMP → PKA phosphorylation of L type Ca2+ channels
1. positive chronotropic effect
2. positive inotropic effect
3. ↑ A-V conduction = ↓ PR interval + ↑ hr
4. shortens ventricular AP duration
5. ↑ purkinje fiber rhythmicity
6. facilitates generation of EADs and DADs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Muscarine

A

M2 receptor agonist = parasympathetic stimulation of supraventricular tissues
Gi → ↓ AC → ↓cAMP
1. negative chronotropic effect
2. shortens ap duration + reduces refractory period (atria)
3. blocks A-V conduction = ↑ PR interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Atropine

A

tachycardia + ↑ AV conduction
muscarinic antagonist = ↓ parasympathetic tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Quinidine, Procainamide, Dysopyramide

A

Class 1a anti-arrhythmics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lidocaine

A

Class 1b anti-arrhythmics
Na+ channel blocker → direct effect on cardiac myocytes
use dependent effect = only slows rate of rise of phase 0 in damaged tissue (blocking action is more potent when ion channels are open)
↓ automaticity
good for ventricular arrhythmias
short half life (~20min)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Propafenone, Encainide, Flecainide

A

Class 1c anti-arrhythmics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Propanolol + Metoprolol

A

B-blockers
Class 2 anti-arrhythmics → predominant action on sinus node
negative chronotropic + inotropic effects
contraindicated in acute hf, asthma, arrhythmias w AV block

anti-anginal drugs - prolong diastolic time
↓ hr = ↑ coronary perfusion time
↓ bp = ↓ afterload = ↓ cardiac work
used to prevent re-infarction after first MI (prophylaxis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Amiodarone

A

Class 3 anti-arrhythmics
K+ channel blockers = prolong ap duration (phase 3)→ longer refractory period
adverse effects:
- iodine toxicity: requires monitoring
- TdP → long QT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Terfenadine

A

(Seldane)
antihistamine → when used with CYP3A4 inhibitor, can lead to TdP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Digoxin

A

cardiac glycosides
uncommonly used anti-arrhythmic
slows AV conduction via ↑ vagal tone = tx of a-fib
low therapeutic window

tx of chronic heart failure
positive inotropic agent = ↑ contractility
negative chronotropic effect = no reflex tachycardia + vasoconstriction
↓ edema = ↑ glomerular circulation

inhibits Na+/K+ ATPase = reduced Na+/Ca2+ exchange = ↓ Ca2+ exiting cell during plateau phase of ap

17
Q

Dobutamine

A

catecholamine - positive inotropic agent
tx of acute heart failure
cardiac B1 agonist = ↑ Ca2+ influx through L type Ca2+ channels
positive chronotropic effect

18
Q

Amrinone

A

+ milrinone
phosphodiesterase inhibitors - positive inotropic agents
tx of chronic hf - oral or IV administration
↑ cAMP = ↑ Ca2+ = ↑ contraction of heart

(↓ contraction of vasc smooth m. - cAMP phosphorylates myosin LC kinase = inactivation → relaxation)

19
Q

Glyceryl Trinitrate

A

nitroglycerine
anti-anginal drug - lowers LVEDP
venodilator → reduces workload via ↓ SV + art. pressure
produces coronary vasodilation without producing coronary steal
side effects: headache + tolerance

20
Q

Acetylsalicylic acid

A

aspirin
emergency tx + prophylaxis of acute myocardial infarction
breaks up clot / prevents clot formation

21
Q

Enalapril, Captopril, Ramapril

A

ACE inhibitors = stop angiotensin II synthesis → vasodilation
Na+ loss = fluid loss; K+ retention
prevent catabolism of bradykinin = antihypertensive
↓ afterload, ↓ preload
adverse effect: dry cough

22
Q

Losartan, Valsartan, Candesartan, Telmisartan

A

Angiotensin receptor antagonists (ARBs)
↓ afterload
no dry cough side effect

23
Q

Hydralazine, Nitroprusside

A

Vasodilators
anti-hypertensives

24
Q

Acetazolamide

A

diuretic
carbonic anhydrase inhibitor (PCT) = excretion of Na+ + HCO3- (natriuresis)
tx: glaucoma, high altitude disorders, epilepsy, urine alkalinization
adverse effects: metabolic acidosis, allergic rxn to sulfa, hypokalemia

25
Mannitol
osmotic diuretic (PCT + desc LoH) tx: ↓ intracranial pressure, cerebral edema, glaucoma
26
Furosemide, Bumetanide
(high ceiling) loop diuretics inhibit NKCC2 in thick asc LoH → natriuresis tx. of hypertension, hf, cirrhosis, edema, nephrotic syndrome adverse effects: hypokalemia, hypomagnesemia, metabolic alkalosis, ototoxicity tx of heart failure - relieve edema + work load (↓ bp) some vasodilatory action high ceiling = ↑ therapeutic flexibility
27
Bartter syndrome
mutations = ↓ function of NKCC2 or ROMK mimic effects of loop diuretics = hyponatremia, -kalemia, -magnesemia
28
Hydrocholorthiazide
diuretic inhibits NCC in DCT → natriuresis tx of hypertension, edema due to nephrotic syndrome, renal disorders, prevention of kidney stone recurrence adverse effects: hypokalemia, -natremia, hyperuricemia, impaired glucose tolerance (↓ insulin release)
29
Chlorthalidone, Indapamide
thiazide-like drugs same mechanism of action, no benzothiadiazine ring
30
Gitelman syndrome
mutation in NCC transporter mimics effects of thiazide diuresis = hypokalemia, metabolic alkalosis
31
Amiloride
K+ sparing diuretic inhibits ENaC in principal cells = natriuresis tx of hf with hypokalemia or hypertension
32
Spironolactone, eplerenone
K+ sparing diuretic competitive antagonists of aldosterone = acts in principal + intercalated cells transcriptional mechanism of action = slow onset of action tx of hf with hypokalemia or hypertension, hyperaldosteronism adverse effect: antiandrogenic effect → gynaecomastia + impotence in males, menstrual irregularities in females tx in hf → renal K+ retention, Na+ loss, H20 loss
33
Tolvaptan
antidiuretic hormone antagonist blocks V2 receptor tx. of hyponatremia (associated with cirrhosis) adverse effect: thirst, polyuria
34
Empagliflozin
SGLT2 inhibitor in PCT = glucosuria + natriuresis used in tx of type 2 diabetes preference: ↓ sympathetic activity, preserved K+ balance, ↓ risk of acute renal injury, ↓ serum uric acid level
35
Dapagliflozin
SGLT2 inhibitor approved tx for hf